Gelteq Ltd(GELS)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Not in ranked universe
Below size threshold
Quality rankings require at least $50M annual revenue or $250M total assets to filter out micro-caps and shell companies. This company reported $0.0M in revenue.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
GELS Stock Analysis & AI Quality Score
AI stock analysis and institutional research for Gelteq Ltd (GELS), a Healthcare sector company. GELS is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least $50m annual revenue or $250m total assets to filter out micro-caps and shell companies. this company reported $0.0m in revenue. Top institutional holders of GELS by reported 13-F value include Private Advisor Group,, CITADEL ADVISORS, TWO SIGMA INVESTMENTS,, based on the most recent SEC filings. GELS trades on the Nasdaq exchange and files with the SEC under CIK 1920092. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GELS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Gelteq Ltd directly from SEC EDGAR.
Get alerted when GELS's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for Gelteq Ltd including:
Top Institutional Holders of GELS
Private Advisor Group, LLC
$11.0K16,668 shCITADEL ADVISORS LLC
$9.0K13,830 shTWO SIGMA INVESTMENTS, LP
$6.6K10,052 shUBS Group AG
$1.2K1,834 shWEDBUSH SECURITIES INC
$13.0020,000 sh
| Fund | Value | Shares |
|---|---|---|
| Private Advisor Group, LLC | $11.0K | 16,668 |
| CITADEL ADVISORS LLC | $9.0K | 13,830 |
| TWO SIGMA INVESTMENTS, LP | $6.6K | 10,052 |
| UBS Group AG | $1.2K | 1,834 |
| WEDBUSH SECURITIES INC | $13.00 | 20,000 |
More Healthcare Companies
View all Healthcare →Put GELS on your watchlist
Track score changes the day Gelteq Ltd files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is GELS a good stock to buy?
13F Pro's AI-powered analysis of Gelteq Ltd (GELS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GELS are available on the GELS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own GELS?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GELS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Gelteq Ltd's investment landscape.